龙湖(00960.HK)合景(01813.HK)启德「尚-?(水盈)」为已打疫苗人士提供额外1%折扣
合景泰富(01813.HK) 及龙湖集团(00960.HK) 合作发展的启德「尚-?(水盈)」项目宣布,向已接种一剂或以上2019冠状病毒病疫苗的买家,提供额外1%折扣优惠。
龙湖集团香港营销总监黄少鸿表示,该项目自去年4月起一直提供为医护人员售价1%的置业折扣,为了鼓励香港市民接种疫苗,现将优惠扩展至已接种新冠疫苗的人士。
合景泰富海外拓展部香港区总经理苏维文表示,期望透过今次优惠提升疫苗接种率,以保障社区健康。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.